Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Over the years, medical researchers have introduced several therapeutic agents to curb the epidemic of obesity
Kidney or liver conditions
Although GLP-1 medications have transformed obesity treatment, there remains a significant need for rigorous data examining how these therapies affect fertility and reproductive function in this population. The RESTORE study is currently evaluating semaglutide treatment in girls and women with PMOS and obesity, with the overarching goal of determining whether weight loss and metabolic improvements can restore ovulation and improve reproductive outcomes
Glucose, A1C, kidney markers, electrolytes, liver-related tests, lipids, and selected nutritional biomarkers can provide objective information about treatment response and possible complications
I had the typical amount of nausea, which occurred 2-3 times per week and lasted approximately 5 minutes
US$ 22.21
US$ 20.63
US$ 27.65
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 22.45
US$ 24.57
